CEO Round Table one of the most significant events of the 2nd edition of India Pharma Week - CJP uploads online petition in Ram Janmabhoomi-Babri Masjid case for Peace in Ayodhya - First Trio of Trade Fairs comprising pacprocess India, indiapack and food pex India is Ready to Kick Off - Teesta Setalvad urges people to join CJP to fight against injustices - Grandest Celebration Of UBM India’s 11th Edition Of CPhI & P-MEC India Gets Underway Today At MMRDA GROUND, BKC - OSH India 2017: Enhancing safety and well-being of the Indian workforce - The ‘India Pharma Week’ returns with a week full of avant-garde events alongside CPhI and P-MEC India - The President of India, Shri Ram Nath Kovind confers National Award for Child Welfare 2017 on The Akshaya Patra Foundation - Sri Sathya Sai International Veda Conference Event organized to mark the 92nd birthday celebrations of Bhagawan Sri Sathya Sai Baba - HDFC Standard Life Insurance Company Limited listed today at NSE in Mumbai with a premium - IIFL’s becomes India’s 1st listed discount brokerage company; offers stock trading at zero brokerage flat fee of Rs 10 per trade - IndiaFirst Life launches Little Champ Plan - ANMI identifies new frontiers of growth for financial services amid a changing regulatory environment - Shri Dinabandhu Mohapatra, MD & CEO,Bank of India, announces the bank's Q2FY18 results - SRCC Children’s hospital launches Raksha Camp – Save the Little Hearts in association with Chief Minister’s Relief Fund and Tata Trusts - The Titan Raga-Masaba Collection Comprises Striking watch designs and motifs that celebrate the Modern Indian woman! - UBM India brings in the 12th edition of Food Ingredients India & Health Ingredients in Mumbai - UBM India unveils the 9th edition of India Nuclear Energy (INE) - Arvind Fashions and Anup Engineering set to become independent of parent Arvind Limited - Sanjay Lalbhai, CMD, Arvind Ltd announces Q2FY18 consolidated results for the 2nd quarter ended Sep. 30, 2017.
  Print Print |  E-mail

Rohto Pharmaceutical Co., Ltd., Japan Forges a Capital & Business Alliance with

(From L-R)- Koji Suzuki - Managing director Rohto ( India ):Ryoji Noda - Consul - General of Japan – Mumbai:Dr. Lekh Raj Juneja - Executive Vice President Rhoto Pharma Pvt. Ltd: B.L. Mittal - Founder & Executive Chairman , Sastasundar Healthbuddy Ltd.;Miyuki Eguchi - Consul - Economic Section; Ravikanth Sharma - Managing Director & CEO , Sastasundar Healthbuddy Ltd. at press conference in Mumbai - Photo By Sachin Murdeshwar GNS(From L-R)- Koji Suzuki - Managing director Rohto ( India ):Ryoji Noda - Consul - General of Japan – Mumbai:Dr. Lekh Raj Juneja - Executive Vice President Rhoto Pharma Pvt. Ltd: B.L. Mittal - Founder & Executive Chairman , Sastasundar Healthbuddy Ltd.;Miyuki Eguchi - Consul - Economic Section; Ravikanth Sharma - Managing Director & CEO , Sastasundar Healthbuddy Ltd. at press conference in Mumbai - Photo By Sachin Murdeshwar GNS

Mumbai, 31st May, 2017 -Sachin Murdeshwar (GNS) :Rohto Pharmaceutical Co., Ltd. (“Rohto”) Japan, today, announced a Capital and Business Alliance with SastaSundar Healthbuddy Limited, a wholly owned subsidiary of SastaSundar Ventures Limited, an NSE and BSE listed company, owning and operating, a leading digital network of healthcare in India. Rohto has invested $5 million (Rs 32.2 crores) in SastaSundar Healthbuddy Limited and is likely to make further investments as the business progresses.

Dr. Lekh Raj Juneja, Executive Vice-President & Global Head International Business of Rohto, Mr. B. L. Mittal, Founder & Executive Chairman, SastaSundar Healthbuddy Limited, His Excellency, Mr. Ryoji Noda (Consul General of Japan in Mumbai), Mr. Koji Suzuki, Managing Director, Rohto Pharma (India) Pvt Ltd& Mr. Ravi Kant Sharma, Managing Director & CEO, SastaSundar Healthbuddy Limited were present to announce this grand alliance.

Established in 1899, Rohto initially played a role in every customer’s welfare with its drugs including unique eye drops and  gastrointestinal medicines. Later, the company successfully ventured into dermal medicines, skin care, and functional foods. Rohto, a global leader, selling and marketing its products in more than 120 countries, aspires to become a company that challenges itself for “healthy life span” through both advanced life science and daily lifestyle based on technological expertise. Rohto entered India in 2010, by establishing its wholly-owned subsidiary ‘Rohto Pharma (India) Pvt. Ltd.’, with its leading lip care brand ‘LipIce’. The following year it launched a range of products including ‘LipIce Color’ under its brand LipIce. Subsequently, it launched two new brands – OXY’ specialised skin care range for men, and Acnes for specialised acne care, in India. is building India’s leading digital network of healthcare, managing efficient pharma & wellness products’ supply chain & connecting doctors, diagnostic services, healthcare clinics and health information services. Currently, is operating in West Bengal only and will expand to pan India. The digital network of is being built upon the online to offline model of healthcare delivery leveraging technology and inventory less service centre of the franchise called Healthbuddy. For the year ended March 2017, the GMV of was Rs.153 crores and it delivered close to 17 lacs orders. As on date, it has 178 Healthbuddy stores with 4.40 lacs registered customers. has portfolio of its own brand which includes unique line of customised health supplement called DNAVITA, authentic herbal products in the brand of Healthbuddy and toxin free beauty care – Zerotox. Apart from this product line, it has health information services through its channel “Know Health” which consists of Health Articles, Medicine Info and Substitute of Generic Medicines, Symptoms Checker and Health Tools. provides customised app using artificial intelligence and has unique service capability based upon health condition data.

“Rohto is looking for the expansion of its base in India with as its preferred partner in the e-commerce business. has shown significant growth in a short span since starting their operations and we were indeed impressed with their business model and hence decided to invest. Rohto will assist in scaling its operations pan-India with our global expertise. Rohto embraces this entrepreneurial opportunity as the friendship between the two great nations of India and Japan. With this alliance, we will in our small ways contribute towards attaining the Hon’ble Prime Minister Of India, Mr Narendra Modi’s vision of Make-in-India and Digital India initiative”, said Dr Lekh Raj Juneja, Exective Vice-President & Global Head International Business of Rohto.

“At, we use knowledge and digital connectivity to reduce cost and add convenience in making available high quality medicines, healthcare products and services through fast online access and convenient home delivery process to make life simple and happy. We are extremely proud to have Rohto joining hands with us, which will be mutually beneficial. As we are on a growth path and looking for a pan-India expansion, we plan to scale up our operations in Mumbai soon. Our association with Rohto will help us in achieving our immediate goal”, said Mr BL Mittal, Founder & Executive Chairman, SastaSundar Healthbuddy Limited.

SastaSundar aims to have a total of 250 Healthbuddy stores in West Bengal & 50 Healthbuddy stores in Delhi by March 2018.

“By utilising the network of SastaSundar we will be introducing well-acclaimed products from our global brands in the healthcare segment in India. This will also help us in expanding our footprints in India, which is a key emerging market for us”, added Dr Juneja.

“Partnership of Rohto and will address one of the biggest problem of India – consistent access to affordable healthcare in a convenient manner”, added Mr Mittal.

India is one of the largest manufacturers of medicines in the world and boasts of the best of doctors. Yet, the majority of Indians do not have access to consistent and affordable healthcare. This is where the association between Rohto and SastaSundar will play a major role in connecting the missing link by leveraging digital technology.